The first insubria autumn school on neuroimmunopharmacology: Challenging paradigms beyond boundaries

Journal of Neuroimmune Pharmacology

Volumn 8, Issue 1, 2013, Pages 1-3

  Cosentino, Marco ^a   Gendelman, Howard E ^b  

^a UNIVERSITY OF INSUBRIA   (Italy)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Insubria autumn school; Neuroimmune pharmacology; Teaching

Indexed keywords

ALLERGIC ENCEPHALOMYELITIS; AUTOIMMUNE DISEASE; CARDIOVASCULAR DISEASE; DEGENERATIVE DISEASE; IMMUNOPHARMACOLOGY; MEDICAL EDUCATION; MEDICAL SCHOOL; MEDICAL SOCIETY; MESENCHYMAL STEM CELL TRANSPLANTATION; MULTIPLE SCLEROSIS; NEOPLASM; NEUROIMMUNOLOGY; NEUROIMMUNOPHARMACOLOGY; NEUROPHARMACOLOGY; PARKINSON DISEASE; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; PSYCHOPHYSIOLOGY; REVIEW;

ALLERGY AND IMMUNOLOGY; HISTORY, 20TH CENTURY; HUMANS; NEUROLOGY; NEUROPHARMACOLOGY; TEXTBOOKS AS TOPIC;

EID: 84873458832     PISSN: 15571890     EISSN: 15571904     Source Type: Journal    
DOI: 10.1007/s11481-013-9440-1     Document Type: Review

References (15)

1. Accolla R, Tosi G (2012) Adequate Antigen Availability: a key issue for novel approaches to tumor vaccination and tumor immunotherapy. J Neuroimmune Pharmacol (in press)
2. Ader R, Cohen N (1975) Behaviorally conditioned immunosuppression. Psychosomatic Med 37:333-40
3. Blandini F (2013) Neural and immune mechanisms in the pathogenesis of Parkinson's disease. J Neuroimmune Pharmacol (in press)
4. Businaro R (2012) Neuroimmunology of the atherosclerotic plaque: a morphological approach. J Neuroimmune Pharmacol (in press)
5. Chang SL, Cabral GA (2011) Education mission for neuroimmune pharmacology. J Neuroimmune Pharmacol 6:1-3
6. Cosentino M, Marino F (2012) Adrenergic and dopaminergic modulation of immunity in multiple sclerosis: teaching old drugs new tricks? J Neuroimmune Pharmacol (in press)
7. Giatti S, Boraso M, Abbiati F, Ballarini E, Calabrese D, Santos-Galindo M, Rigolio R, Pesaresi M, Caruso D, Viviani B, Cavaletti G, Garcia-Segura LM, Melcangi RC (2012) Multimodal analysis in acute and chronic experimental autoimmune encephalomyelitis. J Neuroimmune Pharmacol (in press)
8. Hadamitzky M, Engler H, Schedlowski M (2012) Learned immunosuppression: extinction, renewal, and the challenge of reconsolidation. J Neuroimmune Pharmacol (in press)
9. Hein AM, O'Banion MK (2012) Neuroinflammation and cognitive dysfunction in chronic disase and aging. J Neuroimmune Pharmacol 7:3-6
10. Ippoliti F, Canitano N, Businaro R (2012) Stress and obesity as risk factors in cardiovascular disease: a neuroimmune perspective. J Neuroimmune Pharmacol (in press)
11. Prager G, Hadamitzky M, Engler A, Doenlen R, Wirth T, Pacheco-López G, Krügel U, Schedlowski M, Engler H (2012) Amygdaloid signature of peripheral immune activation by bacterial lipopolysaccharide or staphylococcal enterotoxin B. J Neuroimmune Pharmacol (in press)
12. Roy S (2011) Drugs of abuse effects on immunity and microbial pathogenesis. J Neuroimmune Pharmacol 6:435-8
13. Sacerdote P, Franchi S, Moretti S, Castelli M, Procacci P, Magnaghi V, Panerai AE (2012) Cytokine modulation is necessary for efficacious treatment of experimental neuropathic pain. J Neuroimmune Pharmacol (in press)
14. Sarkar C, Chakroborty D, Basu S (2012) Neurotransmitters as regulators of tumor angiogenesis and immunity: the role of catecholamines. J Neuroimmune Pharmacol (in press)
15. Soldan SS, Jacobson S (2010) Viral infections of the central nervous system: pathogenesis to therapeutics. J Neuroimmune Pharmacol 5:267-70